作者: Werle Martin , Föger Florian
DOI:
关键词:
摘要: The present invention relates to a pharmaceutical composition for transmucosal administration, comprising peptide or protein drug in combination with an excipient pKa value of 12 higher (e.g., arginine free base, EDTA tetrasodium salt, trisodium phosphate, tris(hydroxymethyl)aminomethane, lysine, calcium hydroxide).